Dermal Laboratories Ltd
Kirti Srikakulapu is an experienced Pharmaceutical Development Manager currently employed at Dermal Laboratories Limited since December 2023. Prior to this role, Kirti held various positions at PCI Pharma Services, including Pharmaceutical Development Manager and Head of Formulation Development, from October 2017 to December 2023, as well as Process Development Scientist from May 2017 to August 2017. Kirti's earlier experience includes working as a Formulation Development Scientist at Patheon from June 2015 to April 2017 and at RB from March 2013 to May 2015. Kirti holds a B.Pharmacy degree in Pharmaceutical Sciences from Aston University, obtained between 2010 and 2012, and attended Osmania University from 2006 to 2010.
This person is not in any offices
Dermal Laboratories Ltd
Founded by a doctor in 1963, Dermal Laboratories, part of the family-owned Diomed Group, is one of the few truly independent UK pharmaceutical companies. For over 60 years we have focused on researching and developing innovative topical treatments primarily for prescription. A thorough understanding of the structure and biochemistry of the skin, the performance of the whole formulation, combined with recognising the concerns of healthcare professionals and the needs of patients, has been paramount in the design of Dermal’s topical treatments. This has led to significant advances in treatment through enhanced product efficacy and patient adherence. Dermal’s products are well known amongst Dermatologists, General Practitioners, Nurses and Pharmacists, and are widely prescribed for the treatment of a variety of skin disorders, as well as other conditions which can be treated by applied medication. A strong focus on excellence and reliability ensures we meet the highest standards of quality and performance while also prioritising sustainability and environmental responsibility.